Not Making Headlines: Japan’s Kowa Company Finds Ivermectin is Effective Against Omicron and Other COVID-19 Variants as Phase 3 Trials Continue

Continue reading Not Making Headlines: Japan’s Kowa Company Finds Ivermectin is Effective Against Omicron and Other COVID-19 Variants as Phase 3 Trials Continue